Gentian Diagnostics ASA

Earnings Release • May 15, 2018

First Quarter Financial Report

First Quarter Financial Report

Moss, 15 May 2018

Gentian Diagnostics AS announces its results for the first quarter of 2018. The highlights include:

- Record level for total operating revenue of MNOK 11.2 for the quarter

- 100% growth in sales revenue compared to 1Q17

- 24 % growth in sales revenue compared to 4Q17

- Strong sales for both Cystatin C and fCal

- New Proof-of-Concept announced post end of quarter

Please find the report enclosed. The report will also be made available on www.gentian.no.

For further information, please contact:

Bård Sundrehagen

CEO, Gentian Diagnostics

E-mail: bard.sundrehagen@gentian.no

Cell Phone: +47 924 14 117

Njaal Kind

CFO, Gentian Diagnostics

E-mail: njaal.kind@gentian.no

Cell Phone. +47 919 06 525